Buscar
Mostrando ítems 1-10 de 88
Correlação entre os marcadores para o virus das hepatites tipo B, tipo Delta e tipo C, e parâmetros imunológicos e epidemiológicos em pacientes portadores do vírus da imunodeficiência humana
(Universidade Federal de São Paulo (UNIFESP), 1993)
Hepatitis delta in patients with resolved hepatitis B virus infection
Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals ...
TÉCNICAS DE BIOLOGÍA MOLECULAR PARA LA DETECCIÓN DEL VIRUS DE HEPATITIS DELTA I: OBTENCIÓN DE LA SONDA DIAGNOSTICA ESPECÍFICA
(REVISTA DE LA SOCIEDAD VENEZOLANA DE GASTROENTEROLOGIA (gen), 2017)
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
Background Hepatitis delta virus (HDV) is a defective agent that only replicates in the presence of the hepatitis B virus. Accordingly, HDV acquisition may occur as superinfection of HBsAg+ carriers or following acute dual ...
Hepatitis delta in patients hospitalized in Spain (1997-2018)
BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...
Prevalência dos marcadores para o vírus da hepatite B, anticorpos anti-vírus da hepatite delta e anticorpos anti-virus da hepatite C em pacientes com síndrome de imunodeficiência adquirida
(Universidade Federal de São Paulo (UNIFESP), 1991)
Caracterización serológica y molecular de la infección por el virus de la Hepatitis B y virus de la Hepatitis Delta en comunidades indígenas de ColombiaSerological and molecular characterization of Hepatitis B Virus and Hepatitis Delta Virus infection in indigenous communities from Colombia
(Grupo de GastrohepatologíaMedellín - Colombia, 2022)
Treatment of hepatitis delta and HIV infection
Hepatitis delta virus (HDV) is a defective agent that only infects individuals with hepatitis B virus (HBV). Around 5–10% of chronic hepatitis B patients worldwide are superinfected with HDV, which means 15–25 million ...